Mahsa Asadollahi Hamedani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mahsa Asadollahi Hamedani has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Mohamad Khaledi
Department of Nursing, Faculty of Nursing and Midwifery, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
3 shared publications - Reyhaneh Sadeghian
Department of Nursing, Faculty of Nursing and Midwifery, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
3 shared publications - Amirhossein Khoshghadam
Department of Occupational Health, Tehran Islamic Azad University of Medical Sciences, Tehran, Iran
2 shared publications - Baharak Maddahi
Pediatric Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications - Elahe Zaremoghadam
Department of Internal Medicine, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran
2 shared publications - Fariba Jafari Khabaz
Department of Nursing, Faculty of Nursing and Midwifery, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
2 shared publications
Latest Publications
- 1 January 2026
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 14 (1) , e13315
Beyond deficiency; bidirectional metabolic dysregulation between adipose tissue inflammation and vitamin D bioavailability in pediatric obesity
Pediatric obesity is characterized by a bidirectional metabolic dysregulation of vitamin D metabolism within adipose tissue, creating a state of functional deficiency that standard serum measurements often underestimate. Expanded adipose mass acts as a volumetric sink, sequestering fat-soluble vitamin D metabolites and contributing to low circulating 25-hydroxyvitamin D levels, inversely correlated with body fat. Crucially, adipose tissue inflammation drives profound local metabolic disruption, where pro-inflammatory cytokines (TNF-α, IL-6) down-regulate the activating enzyme CYP27B1 (1α-hydroxylase) and upregulate the degrading enzyme CYP24A1 (24-hydroxylase) in adipocytes and macrophages. This ‘double hit’ severely diminishes 1,25-dihydroxyvitamin D [1,25(OH)2D] within the adipose microenvironment, impairing vitamin D receptor (VDR) signaling precisely where it is needed to suppress inflammation. Systemic inflammation further compromises vitamin D status by reducing hepatic CYP2R1 activity, limiting the conversion of vitamin D to 25(OH) D. Additionally, obesity-associated alterations in vitamin D-binding protein (DBP) levels and isoforms may reduce the bioavailable (free) fraction of vitamin D metabolites, exacerbating tissue-level deficiency despite potentially borderline total serum 25(OH)D. Consequently, the combination of sequestration, inflammation-induced dysregulation of activating/degrading enzymes, and altered binding protein dynamics creates a significant disconnect, where standard serum 25(OH)D levels fail to reflect the critical local deficiency of bioactive vitamin D within the inflamed adipose tissue of obese children. This tissue-specific functional deficiency, driven by inflammation, underpins the impaired immunomodulation and perpetuates metabolic dysfunction, highlighting the inadequacy of conventional vitamin D assessment in obesity and necessitating consideration of bioavailability and tissue metabolism.
- 1 January 2026
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 14 (1) , e13315
Beyond deficiency; bidirectional metabolic dysregulation between adipose tissue inflammation and vitamin D bioavailability in pediatric obesity
Pediatric obesity is characterized by a bidirectional metabolic dysregulation of vitamin D metabolism within adipose tissue, creating a state of functional deficiency that standard serum measurements often underestimate. Expanded adipose mass acts as a volumetric sink, sequestering fat-soluble vitamin D metabolites and contributing to low circulating 25-hydroxyvitamin D levels, inversely correlated with body fat. Crucially, adipose tissue inflammation drives profound local metabolic disruption, where pro-inflammatory cytokines (TNF-α, IL-6) down-regulate the activating enzyme CYP27B1 (1α-hydroxylase) and upregulate the degrading enzyme CYP24A1 (24-hydroxylase) in adipocytes and macrophages. This ‘double hit’ severely diminishes 1,25-dihydroxyvitamin D [1,25(OH)2D] within the adipose microenvironment, impairing vitamin D receptor (VDR) signaling precisely where it is needed to suppress inflammation. Systemic inflammation further compromises vitamin D status by reducing hepatic CYP2R1 activity, limiting the conversion of vitamin D to 25(OH) D. Additionally, obesity-associated alterations in vitamin D-binding protein (DBP) levels and isoforms may reduce the bioavailable (free) fraction of vitamin D metabolites, exacerbating tissue-level deficiency despite potentially borderline total serum 25(OH)D. Consequently, the combination of sequestration, inflammation-induced dysregulation of activating/degrading enzymes, and altered binding protein dynamics creates a significant disconnect, where standard serum 25(OH)D levels fail to reflect the critical local deficiency of bioactive vitamin D within the inflamed adipose tissue of obese children. This tissue-specific functional deficiency, driven by inflammation, underpins the impaired immunomodulation and perpetuates metabolic dysfunction, highlighting the inadequacy of conventional vitamin D assessment in obesity and necessitating consideration of bioavailability and tissue metabolism.
- Open Access
- 12 October 2025
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 14 (4) , e38692
Twenty years of world kidney day; a review of its mission and milestones
World Kidney Day (WKD), established in 2006, marks a pivotal milestone in 2026 as it celebrates its 20th anniversary. This event was first observed on March 9, 2006, as a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF), now known as the International Kidney Foundation – World kidney alliance (IKF-WKA). The primary objective was to raise global awareness about the increasing burden of kidney diseases and to promote preventive behaviors and equitable access to care. Since its inception, WKD has grown into a powerful global movement, celebrated annually on the second Thursday of March by several countries across six continents. As WKD approaches its 20th anniversary in 2026, it offers a timely opportunity to reflect on two decades of achievements, challenges, and lessons learned. Over the past two decades, WKD has evolved from a modest awareness initiative into a globally recognized health campaign, uniting healthcare professionals, policymakers, and patient advocacy groups in the efforts against kidney disease. Finally, this event highlights the importance of addressing chronic kidney disease through awareness, prevention, screening, and comprehensive management to improve outcomes and reduce the global health burden of kidney disease.
- 12 October 2025
- Published by Maad Rayan Publishing Company in Journal of Renal Injury Prevention
- Vol. 14 (4) , e38692
Open AccessTwenty years of world kidney day; a review of its mission and milestones
World Kidney Day (WKD), established in 2006, marks a pivotal milestone in 2026 as it celebrates its 20th anniversary. This event was first observed on March 9, 2006, as a joint initiative of the International Society of Nephrology (ISN) and the International Federation of Kidney Foundations (IFKF), now known as the International Kidney Foundation – World kidney alliance (IKF-WKA). The primary objective was to raise global awareness about the increasing burden of kidney diseases and to promote preventive behaviors and equitable access to care. Since its inception, WKD has grown into a powerful global movement, celebrated annually on the second Thursday of March by several countries across six continents. As WKD approaches its 20th anniversary in 2026, it offers a timely opportunity to reflect on two decades of achievements, challenges, and lessons learned. Over the past two decades, WKD has evolved from a modest awareness initiative into a globally recognized health campaign, uniting healthcare professionals, policymakers, and patient advocacy groups in the efforts against kidney disease. Finally, this event highlights the importance of addressing chronic kidney disease through awareness, prevention, screening, and comprehensive management to improve outcomes and reduce the global health burden of kidney disease.
- Open Access
- 15 April 2025
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 13 (1) , e13289
Mobile radiation’s impact on thyroid health-focused on pediatric population; a review of literature
Since evidence suggesting a direct link between mobile phone radiation and thyroid cancer is not conclusive, emerging studies indicate its biological effects on thyroid function among heavy users. The impact of mobile radiation on pediatric thyroid health warrants serious consideration as mobile technology becomes increasingly pervasive in children’s lives. The unique anatomical and physiological vulnerabilities present in children make them particularly susceptible to potential adverse effects from radio frequency electromagnetic radiation. Studies indicate a possible association between mobile radiation exposure and thyroid dysfunction. The complexity of interactions between mobile radiation, individual genetic backgrounds, and persistent health outcomes still needs several studies.
- 15 April 2025
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 13 (1) , e13289
Open AccessMobile radiation’s impact on thyroid health-focused on pediatric population; a review of literature
Since evidence suggesting a direct link between mobile phone radiation and thyroid cancer is not conclusive, emerging studies indicate its biological effects on thyroid function among heavy users. The impact of mobile radiation on pediatric thyroid health warrants serious consideration as mobile technology becomes increasingly pervasive in children’s lives. The unique anatomical and physiological vulnerabilities present in children make them particularly susceptible to potential adverse effects from radio frequency electromagnetic radiation. Studies indicate a possible association between mobile radiation exposure and thyroid dysfunction. The complexity of interactions between mobile radiation, individual genetic backgrounds, and persistent health outcomes still needs several studies.
- Open Access
- 29 July 2023
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 11 (1) , e11213
Impact of vitamin D deficiency on hypertension; a mini-review on recent insights
There is increasing evidence that vitamin D deficiency may contribute to hypertension. Low vitamin D levels are associated with an increased risk of high blood pressure, and studies have shown that vitamin D supplementation can help lower blood pressure. However, more research is needed to fully understand the mechanisms by which vitamin D regulates blood pressure and to determine the optimal dosage for supplementation. Nevertheless, ensuring adequate vitamin D levels through diet or supplements may be essential for preventing and managing hypertension.
- 29 July 2023
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 11 (1) , e11213
Open AccessImpact of vitamin D deficiency on hypertension; a mini-review on recent insights
There is increasing evidence that vitamin D deficiency may contribute to hypertension. Low vitamin D levels are associated with an increased risk of high blood pressure, and studies have shown that vitamin D supplementation can help lower blood pressure. However, more research is needed to fully understand the mechanisms by which vitamin D regulates blood pressure and to determine the optimal dosage for supplementation. Nevertheless, ensuring adequate vitamin D levels through diet or supplements may be essential for preventing and managing hypertension.
- Open Access
- 14 March 2023
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
SARS-CoV-2 Omicron variant; psychological effect and influencing factors in elderly patients
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant appeared in South Africa for the first time. The high prevalence of its mortality in elderly patients has caused an increase in anxiety triggered by this disease in aged people. Objectives: The aim of this study is to evaluate the anxiety related-COVID-19 in the SARS-CoV-2 Omicron variant and its related factors in elderly patients who are candidates for cataract surgery. Patients and Methods: This descriptive-analytical study was conducted on 159 over 65 years old patients who are candidates for cataract surgery. Easy and accessible sampling methods were employed to select samples. Demographic characteristics sheet and the Corona Disease Anxiety Scale (CDAS) questionnaire were filled out by them. Fisher’s exact test, Mann-Whitney U and binary logistic regression tests were conducted for data analysis. Results: The results showed that out of 159 patients, 57.9% were female, with a mean age of 73.09 ± 9.64 years. The anxiety level of 70.4% of patients was mild or non-anxiety and 29.6% was moderate or severe. The correlation between anxiety related to COVID-19 with age, gender, vaccination status and history of being infected by COVID-19 was significant (P0.05). Conclusion: We concluded that older age, female gender, non-vaccinated and having no history of being infected by COVID-19 are the most influential factors that increase anxiety triggered by COVID-19 in elderly patients.
- 14 March 2023
- Published by Maad Rayan Publishing Company in Immunopathologia Persa
Open AccessSARS-CoV-2 Omicron variant; psychological effect and influencing factors in elderly patients
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant appeared in South Africa for the first time. The high prevalence of its mortality in elderly patients has caused an increase in anxiety triggered by this disease in aged people. Objectives: The aim of this study is to evaluate the anxiety related-COVID-19 in the SARS-CoV-2 Omicron variant and its related factors in elderly patients who are candidates for cataract surgery. Patients and Methods: This descriptive-analytical study was conducted on 159 over 65 years old patients who are candidates for cataract surgery. Easy and accessible sampling methods were employed to select samples. Demographic characteristics sheet and the Corona Disease Anxiety Scale (CDAS) questionnaire were filled out by them. Fisher’s exact test, Mann-Whitney U and binary logistic regression tests were conducted for data analysis. Results: The results showed that out of 159 patients, 57.9% were female, with a mean age of 73.09 ± 9.64 years. The anxiety level of 70.4% of patients was mild or non-anxiety and 29.6% was moderate or severe. The correlation between anxiety related to COVID-19 with age, gender, vaccination status and history of being infected by COVID-19 was significant (P0.05). Conclusion: We concluded that older age, female gender, non-vaccinated and having no history of being infected by COVID-19 are the most influential factors that increase anxiety triggered by COVID-19 in elderly patients.
- Open Access
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25120
Biomarkers in IgA nephropathy; an update to recent data
Biomarkers are molecules that can be measured in the body and can reflect disease activity or progression. They can be used to diagnose and monitor disease, predict treatment response, and identify potential therapeutic targets. Several types of biomarkers have been studied in the context of IgA nephropathy, including protein, gene expression, epigenetic, and microRNA biomarkers. Biomarkers have the potential to improve the accuracy and specificity of the diagnosis of IgA nephropathy and predict the disease progression and response to treatment. However, further studies are needed to validate their diagnostic value in larger cohorts of patients and to integrate them into clinical practice. The development of multi-omics approaches that combine different types of biomarkers may provide a more comprehensive understanding of the disease pathogenesis and potential treatments.
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25120
Open AccessBiomarkers in IgA nephropathy; an update to recent data
Biomarkers are molecules that can be measured in the body and can reflect disease activity or progression. They can be used to diagnose and monitor disease, predict treatment response, and identify potential therapeutic targets. Several types of biomarkers have been studied in the context of IgA nephropathy, including protein, gene expression, epigenetic, and microRNA biomarkers. Biomarkers have the potential to improve the accuracy and specificity of the diagnosis of IgA nephropathy and predict the disease progression and response to treatment. However, further studies are needed to validate their diagnostic value in larger cohorts of patients and to integrate them into clinical practice. The development of multi-omics approaches that combine different types of biomarkers may provide a more comprehensive understanding of the disease pathogenesis and potential treatments.
- Open Access
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25102
Kidney stones incidence and related factors in hemodialysis patients: a multi-center study of Iran southeast population
Introduction: In previous studies, kidney stones was reported as a common complication in general populations. Objectives: This study aimed to evaluate kidney stone incidence and related factors in hemodialysis patients. Patients and Methods: This descriptive-analytical study was conducted on 284 hemodialysis patients in the Zahedan. Demographic and clinical data were collected. The incidence rate of kidney stone was calculated. The correlation between kidney stone incidence with predicting factors was explored by multivariate logistic regression. Results: Results demonstrated that most patients were male, with a mean age of 48.81 ± 16.84 years. The correlation between kidney stone incidence with gender, race, smoking, and blood group was not significant (P > 0.05); however, its correlation with diabetes mellitus, urinary tract infection, age, and body mass index (BMI) was significant (P < 0.05). The kidney stone incidence rate was 23.24%, while diabetes mellitus, urinary tract infection, older age, and higher BMI were the most common predictors. Conclusion: Diabetes mellitus, urinary tract infection, older age, and higher BMI were the common predictors for kidney stone incidence in hemodialysis patients. Identifying kidney stone incidence predictors in patients with hemodialysis can be helping in lower complications.
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25102
Open AccessKidney stones incidence and related factors in hemodialysis patients: a multi-center study of Iran southeast population
Introduction: In previous studies, kidney stones was reported as a common complication in general populations. Objectives: This study aimed to evaluate kidney stone incidence and related factors in hemodialysis patients. Patients and Methods: This descriptive-analytical study was conducted on 284 hemodialysis patients in the Zahedan. Demographic and clinical data were collected. The incidence rate of kidney stone was calculated. The correlation between kidney stone incidence with predicting factors was explored by multivariate logistic regression. Results: Results demonstrated that most patients were male, with a mean age of 48.81 ± 16.84 years. The correlation between kidney stone incidence with gender, race, smoking, and blood group was not significant (P > 0.05); however, its correlation with diabetes mellitus, urinary tract infection, age, and body mass index (BMI) was significant (P < 0.05). The kidney stone incidence rate was 23.24%, while diabetes mellitus, urinary tract infection, older age, and higher BMI were the most common predictors. Conclusion: Diabetes mellitus, urinary tract infection, older age, and higher BMI were the common predictors for kidney stone incidence in hemodialysis patients. Identifying kidney stone incidence predictors in patients with hemodialysis can be helping in lower complications.
- Open Access
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25117
Onconephropathology; an emerging field of medicine
Onconephropathology; an emerging field of medicine
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of Renal Endocrinology
- Vol. 9 (1) , e25117
Open AccessOnconephropathology; an emerging field of medicine
Onconephropathology; an emerging field of medicine
- Open Access
- 19 October 2021
- Published by Brieflands in Medical-Surgical Nursing Journal
- Vol. 10 (1)
Effect of Family-centered Empowerment Model on Quality of Life of Patients with Hypertension
Background: Nowadays, the high prevalence of hypertension and its serious complications for affected patients have made this disease a major health issue worldwide. Hypertension, like other chronic diseases, reduces the patients’ quality of life. Maintaining and improving their lifestyles requires the serious support of families. Objectives: This study aimed to explore the effect of the family-centered empowerment model on the quality of life of patients with hypertension. Methods: This clinical trial was performed on 70 hypertensive patients who were referred to two comprehensive health centers in Zahedan University of Medical Sciences in Zahedan, southeastern Iran, in 2020. The participants were selected and randomly allocated based on the inclusion criteria to the intervention (n = 35) and control (n = 35) groups using the consort. The participants in the intervention group received training in four 60-min sessions individually based on the family empowerment model. To collect data, a personal information form and the Quality of Life Questionnaire for hypertensive patients were used. The questionnaire was completed before the intervention and one and three months after the intervention by a self-report method. The collected data were analyzed by SPSS-22 using the independent samples t test, chi-square test, and repeated-measures analysis of variance. Results: The results of repeated-measures analysis of variance regarding the effect of time and group on the quality of life showed a statistically significant difference in the second and third phases between the two groups. In other words, the two variables of intervention and time affected the mean score of quality of life, and a statistically significant difference was observed in the measured time intervals (P < 0.001). Conclusions: This study showed that implementing the family-centered empowerment model improves the quality of life of patients with hypertension. Therefore, we recommend employing this method by nurses to engage the patients with chronic diseases and their families in the process of treatment.
- 19 October 2021
- Published by Brieflands in Medical-Surgical Nursing Journal
- Vol. 10 (1)
Open AccessEffect of Family-centered Empowerment Model on Quality of Life of Patients with Hypertension
Background: Nowadays, the high prevalence of hypertension and its serious complications for affected patients have made this disease a major health issue worldwide. Hypertension, like other chronic diseases, reduces the patients’ quality of life. Maintaining and improving their lifestyles requires the serious support of families. Objectives: This study aimed to explore the effect of the family-centered empowerment model on the quality of life of patients with hypertension. Methods: This clinical trial was performed on 70 hypertensive patients who were referred to two comprehensive health centers in Zahedan University of Medical Sciences in Zahedan, southeastern Iran, in 2020. The participants were selected and randomly allocated based on the inclusion criteria to the intervention (n = 35) and control (n = 35) groups using the consort. The participants in the intervention group received training in four 60-min sessions individually based on the family empowerment model. To collect data, a personal information form and the Quality of Life Questionnaire for hypertensive patients were used. The questionnaire was completed before the intervention and one and three months after the intervention by a self-report method. The collected data were analyzed by SPSS-22 using the independent samples t test, chi-square test, and repeated-measures analysis of variance. Results: The results of repeated-measures analysis of variance regarding the effect of time and group on the quality of life showed a statistically significant difference in the second and third phases between the two groups. In other words, the two variables of intervention and time affected the mean score of quality of life, and a statistically significant difference was observed in the measured time intervals (P < 0.001). Conclusions: This study showed that implementing the family-centered empowerment model improves the quality of life of patients with hypertension. Therefore, we recommend employing this method by nurses to engage the patients with chronic diseases and their families in the process of treatment.